论文部分内容阅读
目的:讨论Ⅱ型前列腺炎患者前列腺结石、前列腺液白细胞数及临床症状相关性。方法:我院门诊2009年1月至2011年12月就诊的327例Ⅱ型前列腺炎患者纳入研究。所有患者治疗前均行前列腺液白细胞计数、经腹前列腺彩超和慢性前列腺炎症状指数评分(CPSI),将结果进行统计学分析。结果:所有Ⅱ型前列腺炎患者的前列腺结石直径和前列腺液中白细胞计数两者有相关性,差异具有统计学意义(P<0.05),前列腺结石直径和NIH-CPSI评分、前列腺液白细胞计数和NIH-CPSI评分均无相关性(P>0.05)。根据前列腺结石直径将患者进行分组,不同组别的患者的前列腺液白细胞计数不同,其差异有统计学意义(P<0.05),NIH-CPSI评分组间差异无统计学意义(P>0.05)。结论:Ⅱ型前列腺炎患者就诊时前列腺结石、前列腺液白细胞计数和前列腺炎患者临床症状无明细相关性,因此Ⅱ型前列腺炎患者前列腺结石情况和前列腺液白细胞计数一样不能作为独立因素评估前列腺炎的临床症状的严重性并用于指导治疗。
Objective: To discuss the relationship between prostatic stones, prostatic fluid leukocyte count and clinical symptoms in type Ⅱ prostatitis patients. Methods: 327 patients with type Ⅱ prostatitis admitted from January 2009 to December 2011 in our hospital were included in the study. Prostatic fluid white blood cell count, prostatic ultrasonography and chronic prostatitis symptom score (CPSI) were used in all patients before treatment, and the results were statistically analyzed. Results: There was a significant correlation between the diameter of prostatic stones and the number of leukocytes in prostatic fluid (P <0.05), the diameters of prostatic stones and the NIH-CPSI score, the prostatic fluid leukocyte count and NIH -CPSI scores were not related (P> 0.05). According to the diameter of prostatic stones, the patients were divided into groups. Prostatic fluid leukocyte counts were different in different groups (P <0.05). There was no significant difference between the NIH-CPSI scores (P> 0.05). Conclusions: Prostate stones, prostatic fluid leukocyte count and clinical symptoms of prostatitis patients are not related in detail at the time of diagnosis. Prostate stones in patients with type Ⅱ prostatitis can not be used as independent factors to evaluate prostatitis, like prostatic fluid leukocyte count The severity of clinical symptoms and used to guide treatment.